ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
26.64 USD
-0.98 (-3.55%)
26.64 USD
0 (0%)
Taking everything into account, ENOV scores 4 out of 10 in our fundamental rating. ENOV was compared to 186 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ENOV while its profitability can be described as average. ENOV scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year ENOV was profitable.
In the past year ENOV had a positive cash flow from operations.
In multiple years ENOV reported negative net income over the last 5 years.
Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
ENOV has a Return On Assets (-30.84%) which is comparable to the rest of the industry.
The Return On Equity of ENOV (-67.66%) is comparable to the rest of the industry.
ENOV has a better Return On Invested Capital (0.12%) than 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ENOV has a Operating Margin of 0.25%. This is in the better half of the industry: ENOV outperforms 65.05% of its industry peers.
ENOV's Operating Margin has declined in the last couple of years.
The Gross Margin of ENOV (57.19%) is comparable to the rest of the industry.
ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
ENOV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ENOV has more shares outstanding than it did 1 year ago.
ENOV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ENOV is higher compared to a year ago.
2.2 Solvency
ENOV has an Altman-Z score of 0.78. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.78, ENOV perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of ENOV is 59.72, which is on the high side as it means it would take ENOV, 59.72 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 59.72, ENOV is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
ENOV has a Debt to Equity ratio of 0.66. This is in the lower half of the industry: ENOV underperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.78 |
ROIC/WACC0.02
WACC7.21%
2.3 Liquidity
ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
ENOV has a Current ratio of 2.22. This is comparable to the rest of the industry: ENOV outperforms 44.09% of its industry peers.
ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
ENOV has a worse Quick ratio (1.16) than 69.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.14% over the past year.
The earnings per share for ENOV have been decreasing by -16.18% on average. This is quite bad
Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 11.57% in the last year.
Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -8.73% on average per year.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
The Earnings Per Share is expected to grow by 23.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, ENOV will show a quite strong growth in Revenue. The Revenue will grow by 8.87% on average per year.
EPS Next Y14.67%
EPS Next 2Y11.49%
EPS Next 3Y11.76%
EPS Next 5Y23.19%
Revenue Next Year7.42%
Revenue Next 2Y6.02%
Revenue Next 3Y5.88%
Revenue Next 5Y8.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.00, the valuation of ENOV can be described as reasonable.
ENOV's Price/Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 95.70% of the companies in the same industry.
ENOV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
The Price/Forward Earnings ratio is 7.57, which indicates a rather cheap valuation of ENOV.
Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 98.39% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ENOV to the average of the S&P500 Index (23.13), we can say ENOV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8 | ||
| Fwd PE | 7.57 |
4.2 Price Multiples
91.94% of the companies in the same industry are more expensive than ENOV, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ENOV is valued a bit cheaper than the industry average as 71.51% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 66.92 | ||
| EV/EBITDA | 9.58 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y11.49%
EPS Next 3Y11.76%
5. Dividend
5.1 Amount
ENOV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
26.64
-0.98 (-3.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.5%
Inst Owner Change-2.38%
Ins Owners1.2%
Ins Owner Change0.81%
Market Cap1.52B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target47.94 (79.95%)
Short Float %14.97%
Short Ratio9.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-6%
PT rev (3m)-13.5%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)-5.06%
EPS NY rev (1m)1.85%
EPS NY rev (3m)1.83%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8 | ||
| Fwd PE | 7.57 | ||
| P/S | 0.68 | ||
| P/FCF | 66.92 | ||
| P/OCF | 7.02 | ||
| P/B | 0.75 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.58 |
EPS(TTM)3.33
EY12.5%
EPS(NY)3.52
Fwd EY13.2%
FCF(TTM)0.4
FCFY1.49%
OCF(TTM)3.8
OCFY14.25%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.55
PEG (5Y)N/A
Graham Number51.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.78 |
F-Score4
WACC7.21%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y14.67%
EPS Next 2Y11.49%
EPS Next 3Y11.76%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.42%
Revenue Next 2Y6.02%
Revenue Next 3Y5.88%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.68%
EBIT Next 3Y28.42%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
What is the valuation status of ENOVIS CORP (ENOV) stock?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.67% in the next year.